Our study not only revealed a causal relationship between pyruvate metabolism and BC risk, but also found that ADH1B, ACSS2, ACACB, ADH1A, ALDH2, and ADH1C takes place a major part in the development of BC in the molecular mechanisms related to pyruvate metabolism, and identified some potential targeted small molecule drugs. The gene discussed is ALDH2; the disease is breast cancer.